EUVIMED · CrossrefJournal
Lupus Science & Medicine
ISSN 2053-8790 · BMJ
Latest articles
Risk-stratified effectiveness of direct oral anticoagulants versus vitamin K antagonists in thrombotic antiphospholipid syndrome: a prospective cohort study
Measurement of kidney disease in a novel multidomain treatment response measure for SLE clinical trials
Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus
Free mycophenolic acid exposure for therapeutic drug monitoring in paediatric lupus nephritis: associations with treatment response and haematologic toxicity
Grading of intrarenal tertiary lymphoid structure-like aggregates and association with early treatment response in proliferative lupus nephritis
Litifilimab reduces skin and joint disease in participants with SLE: additional results from Part A of the phase II LILAC study
Effect of upadacitinib and ABBV-599 on biomarkers in SLE: results from the phase 2 SLEek study
Impact of deucravacitinib on arthritis in patients with systemic lupus erythematosus: results from the phase II PAISLEY SLE study
Integrated multiomics identifies α-ketoglutarate as a candidate metabolite associated with the renoprotective effect of triptolide in MRL/lpr lupus-prone mice
Development and temporal validation of a clinical prediction model to identify bacterial infection in hospitalised patients with systemic lupus erythematosus
Loss-of-function variant of the immunoregulator TMEM176B is associated with progression to ESKD in SLE
Real-world discontinuation of immunosuppressive therapy after proliferative lupus nephritis: the overlooked impact of non-adherence (MASSILUP-WIN)
Pulmonary function, functional capacity and physical activity in patients with SLE: a cross-sectional study
Maternal and neonatal outcomes in SLE: comparison of 430 pregnancies from the French GR2 study with 1720 pregnancies from French perinatal surveys
Longitudinal clinical course and long-term outcomes of SLE-associated interstitial lung disease
Development of a LASSO-based machine learning model for relapse prediction in lupus nephritis
Antiphospholipid antibody associated retinal microvascular impairment: a case report and literature review
Unsupervised clustering of clinical and laboratory features of systemic lupus erythematosus: insights from a multicentre cohort
Pulmonary diseases in SLE: a population-based cross-sectional study
Real-world experience of anifrolumab treatment in patients with moderate-to-severe SLE: a retrospective study of patients in early access programmes
Evaluation of clinical, histological and biomarker response after initial therapy of lupus nephritis
Impact of an online lupus self-management programme in an established, population-based cohort of adults with diagnosed SLE: a mixed-methods study
Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes
Statin therapy in systemic lupus erythematosus: a meta-analysis of disease activity and inflammatory biomarkers
Intrathecal injection of rituximab inhibits microglial M1 polarisation to alleviate neuropsychiatric SLE symptoms via the cAMP/PKA/CREB signalling pathway
Long-term outcomes of hydroxychloroquine dose reduction in Puerto Ricans with systemic lupus erythematosus: 6-year follow-up
Left Ventricular Mass Index as an independent predictor of major adverse cardiovascular and cerebrovascular events in patients with SLE
Human papillomavirus (HPV) seroprevalence, cervical HPV prevalence and cervical lesions in systemic lupus erythematosus (SLE) and immunocompetent women
Alterations in the DTI-ALPS index and choroid plexus volume as brain–immune interfacing indicators in neuropsychiatric lupus erythematosus with inflammatory phenotype
Adverse childhood experiences are associated with disease and mental health outcomes in childhood-onset SLE
EUVIMED